These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15720368)

  • 1. Whither causal models in the neuroscience of ADHD?
    Coghill D; Nigg J; Rothenberger A; Sonuga-Barke E; Tannock R
    Dev Sci; 2005 Mar; 8(2):105-14. PubMed ID: 15720368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varieties of preschool hyperactivity: multiple pathways from risk to disorder.
    Sonuga-Barke EJ; Auerbach J; Campbell SB; Daley D; Thompson M
    Dev Sci; 2005 Mar; 8(2):141-50. PubMed ID: 15720372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Working toward a neurobiological account of ADHD: commentary on Gail Tripp and Jeff Wickens, dopamine transfer deficit.
    Williams J
    J Child Psychol Psychiatry; 2008 Jul; 49(7):705-11; discussion 711. PubMed ID: 18598242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurocognitive models for attention deficit hyperactivity disorder and their consequences on the searching of endophenotypes].
    Henriquez-Henriquez M; Zamorano-Mendieta F; Rothhammer-Engel F; Aboitiz F
    Rev Neurol; 2010 Jan 16-31; 50(2):109-16. PubMed ID: 20112219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroscience of ADHD: multidisciplinary perspectives on a complex developmental disorder.
    Sonuga-Barke EJ; Sergeant J
    Dev Sci; 2005 Mar; 8(2):103-4. PubMed ID: 15720367
    [No Abstract]   [Full Text] [Related]  

  • 6. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder.
    Aron AR; Poldrack RA
    Biol Psychiatry; 2005 Jun; 57(11):1285-92. PubMed ID: 15950000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?
    Sonuga-Barke EJ; Halperin JM
    J Child Psychol Psychiatry; 2010 Apr; 51(4):368-89. PubMed ID: 20015192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade.
    Nigg JT
    Biol Psychiatry; 2005 Jun; 57(11):1424-35. PubMed ID: 15950017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder.
    Steinhausen HC
    Acta Psychiatr Scand; 2009 Nov; 120(5):392-9. PubMed ID: 19807721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model.
    Sergeant JA
    Biol Psychiatry; 2005 Jun; 57(11):1248-55. PubMed ID: 15949995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences.
    Nigg JT; Casey BJ
    Dev Psychopathol; 2005; 17(3):785-806. PubMed ID: 16262992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collicular dysfunction in attention deficit hyperactivity disorder.
    Overton PG
    Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD?
    Doyle AE; Faraone SV; Seidman LJ; Willcutt EG; Nigg JT; Waldman ID; Pennington BF; Peart J; Biederman J
    J Child Psychol Psychiatry; 2005 Jul; 46(7):774-803. PubMed ID: 15972070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?
    Nigg JT; Willcutt EG; Doyle AE; Sonuga-Barke EJ
    Biol Psychiatry; 2005 Jun; 57(11):1224-30. PubMed ID: 15949992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative neuroscience approach to predict ADHD stimulant response.
    Hermens DF; Rowe DL; Gordon E; Williams LM
    Expert Rev Neurother; 2006 May; 6(5):753-63. PubMed ID: 16734523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive functions in attention-deficit/hyperactivity disorder.
    Doyle AE
    J Clin Psychiatry; 2006; 67 Suppl 8():21-6. PubMed ID: 16961426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ADHD and attachment processes: are they related?].
    Franc N; Maury M; Purper-Ouakil D
    Encephale; 2009 Jun; 35(3):256-61. PubMed ID: 19540412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of attention deficit hyperactivity disorder.
    Kieling C; Goncalves RR; Tannock R; Castellanos FX
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):285-307, viii. PubMed ID: 18295147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.